The quarterly Form 13F deadline landed this week, and with it a run of headlines announcing that Wall Street has discovered XRP. Morgan Stanley, JPMorgan, Wells Fargo and Bank of Montreal all disclosed exposure to XRP exchange-traded products in filings covering the quarter that ended 30 June. Read the coverage and you would think the institutional bid had arrived.
Read the filings and you find something quieter and more useful. The positions are, with one exception, extremely small. None of them is spot XRP. And every number in them describes a portfolio that stopped existing six weeks ago.
That gap — between what a 13F says and what it gets reported to mean — is worth understanding before November's batch.
What was actually filed
Morgan Stanley reported 6,715 shares of the Franklin XRP ETF, 255 shares of the REX-Osprey XRP ETF and 67 shares of the Bitwise XRP ETF. Sixty-seven shares. The bank had previously shown positions in the Grayscale and Volatility Shares XRP products in its first-quarter filing, so this is continuation rather than debut.
Bank of Montreal filed on 12 August and reported $2,970 of XRP-linked ETF shares — 323 shares of the REX-Osprey fund at $2,771 and 20 shares of the ProShares Ultra XRP fund at $199 — inside a reported portfolio of $303.65 billion. That is roughly one part in 102 million. The stake sits within Stoker Ostler Wealth Advisors, a registered adviser BMO controls, which means it is almost certainly a client allocation rolled up into the parent's consolidated filing rather than a decision made anywhere near BMO's balance sheet.
Wells Fargo is the outlier at roughly $9.18 million in the Bitwise XRP ETF, split across two line items of $1.39 million and $7.79 million. Its filing became public on 14 August and is the largest single disclosed institutional position in that fund for the quarter. JPMorgan reported new positions in the Bitwise and Grayscale XRP products alongside its much larger bitcoin ETF book.
Our take: A 13F is a consolidated report of long US-listed holdings across an entire bank holding company — client-directed brokerage accounts, wealth-management sleeves, market-making inventory, hedges against structured products. It is not a conviction list. Sixty-seven shares of an ETF is not a bank taking a view on a token; it is a settlement artefact. Reporting it as institutional endorsement is how a $2,970 line item becomes a "bank adopts XRP" headline.
The line item nobody led with
Both Morgan Stanley and JPMorgan disclosed stakes in Armada Acquisition Corp II, a listed shell linked to Evernorth Holdings — a Ripple-backed vehicle whose stated purpose is building an institutional XRP treasury. Morgan Stanley's holding was 50,540 shares.
That is a more interesting signal than the ETF crumbs, and for a structural reason. Nobody on this list bought spot XRP. Every route taken was a regulated, US-listed wrapper: an ETF, or equity in a company that intends to hold the asset. The wrapper is the entry condition, not an implementation detail. Institutions that cannot hold the token directly can hold a share class that does.
Price context, held lightly: XRP trades roughly 72% below the $3.65 high it set in July 2025. These filings describe 30 June and say nothing about what any desk has done since.
What to watch
- The November filings. Q3 13Fs are the first read on whether these positions grew, shrank or were quarter-end client churn. One quarter of data is an anecdote.
- Whether Armada/Evernorth closes. If the combination completes, the treasury size it discloses is a real number attached to a real balance sheet — unlike a 45-day-old snapshot.
- Weekly ETF flows over quarterly filings. Fund-level flow data updates continuously. We noted US spot XRP funds taking in about $1.01 million across a week earlier this month; that is a live signal, and a modest one.
- What 13Fs structurally miss. They capture long US-listed positions only. Short exposure, derivatives outside reportable classes and non-discretionary assets never appear — a floor on visibility, not a picture.
The honest summary: four large institutions have small, wrapper-mediated, mostly client-driven exposure to XRP products, and one of them — Wells Fargo — has a position large enough to be worth tracking. That is a real fact. It is not the fact the headlines reported.